Skip to main content
Clinical Trials/CTRI/2017/04/008372
CTRI/2017/04/008372
Recruiting
未知

A cross-sectional survey to assess prevalence of xerostomia and related problems among patients who have received teletherapy for head and neck cancer in TMH. - PEBRTXP

Tata Memorial Hospital0 sites60 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- xersotomia in head and neck cancer
Sponsor
Tata Memorial Hospital
Enrollment
60
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Age group: \- 18 and above
  • 2\) Patients who have received radical external beam radiotherapy (EBRT) with or without concurrent chemotherapy.
  • 3\) Those who have completed all planned treatment and have come on their first follow up (8\-12 weeks after completion of EBRT.
  • 4\) Willing to participate in the study.

Exclusion Criteria

  • 1\) Patients receiving adjuvant RT.
  • 2\) Patients who have received a combination of EBRT and Brachytherapy or Brachytherapy alone.
  • 3\) Metastatic cancer.
  • 4\) Co\-morbid condition such as DM, antidepressants, Sâ??jogren syndrome.

Outcomes

Primary Outcomes

Not specified

Similar Trials